Page 13 - Sanket Koul

Eli Lilly to pump $1 billion into India to boost contract manufacturing

The US pharma major to set up a manufacturing and supply hub in Hyderabad as part of a $1 billion investment aimed at boosting contract production in India

Cough syrup deaths: NHRC sends notices to MP, Rajasthan, Uttar Pradesh

NHRC issues notices to MP, Rajasthan and UP, asks states to probe children's deaths from alleged use of contaminated cough syrups

Festival frenzy: Housing market sees room for growth after 3-quarter lull

Developers roll out slew of freebies, incentives to potential buyers

Health Secy reviews GMP norms with states after cough syrup deaths

Union Health Secretary Punya Salila Srivastava chaired a meeting with states after 11 children died in MP and Rajasthan, stressing strict GMP compliance and rational use of cough syrups in children

Centre revises rate structure for nearly 2,000 medical procedures

CGHS hospitals must accept new rates by Oct 13

MP children deaths: Contaminant found in cough syrup made by TN firm

Contaminant found in Coldrif cough syrup; risk-based investigations started at manufacturing sites of around 19 drugs sampled across 6 states

After 7 years, IHH finally gets Sebi go-ahead for Fortis open offer

In 2018, price was set at ₹170/share; Fortis Healthcare now trades at ₹980.10

Govt warns against cough syrup use in kids after 11 deaths in MP, Rajasthan

Health ministry advisory urges rational use of cough syrups in children after 11 deaths in Madhya Pradesh and Rajasthan, though tests found no contamination in samples

IPA appoints Zydus Lifesciences MD Sharvil Patel as new President

Sharvil Patel takes over as President of IPA from Samir Mehta, with Glenn Saldanha appointed Vice President, as the industry navigates reforms and global challenges

Retail REITs set to grow as institutional investors back new malls

Anarock says institutional investors now hold stakes in over 30% of malls, with upcoming Grade A launches and GST reforms driving new retail-focused REIT activity

Madhya Pradesh, Rajasthan probe child deaths linked to cough syrup

Drug authorities in Madhya Pradesh and Rajasthan are probing child deaths linked to cough syrup supplied to government hospitals, with testing of samples and quality concerns

Govt invites proposals under PRIP scheme for pharma, medtech projects

DoP recently notified revised guidelines to make scheme better suited for stakeholders

Leverage Edu targets 2x FY26 revenue on Africa, SE Asia expansion

Leverage Edu is expanding into Africa and Southeast Asia to double FY26 revenue, as Indian students shift away from the US amid visa curbs and new education hubs emerge

Cabinet clears 57 new Kendriya Vidyalayas, 86k students to benefit

The Union Cabinet has approved 57 new Kendriya Vidyalayas with Balvatikas under NEP 2020, with Rs 5,862 crore funding over nine years and focus on underserved districts

Weight-loss drug Ozempic receives CDSCO approval for India launch

Experts say Ozempic's entry is expected to give a boost to the antiobesity market, estimated to be ₹752 crore. Of this market, semaglutide accounts for ₹426 crore

Indian students to gain wider access to education in UK in coming years

With visa curbs in the US, British Council Country Director says students could get dual, joint degrees and credit transfer pathways to improve access

Lupin to acquire VISUfarma BV for €190 mn to expand European eyecare reach

Lupin's unit Nanomi BV will acquire VISUfarma BV from GHO Capital for €190 mn, adding an eyecare portfolio across Europe and strengthening its ophthalmology franchise

Delhi diagnostic players oppose genetic sample outflow ban order

Move was put in place after Delhi saw a fall in sex ratio at birth for 4th straight year, with officials fearing a return of prenatal gender testing

India's pharma exports unlikely to be affected amid Tylenol debate: Experts

Data shows India's paracetamol exports to the US are modest, accounting for less than one per cent of API shipments, despite global attention on the Tylenol controversy

NPPA extends knee implant price ceiling till November 2025 amid review

The NPPA has extended the ceiling price for knee implants till November 2025 while considering industry pleas for removal, citing rising costs and supply chain issues